Mandate

Vinge assist Marguerite in the acquisition and project financing of the Brännliden wind farm.

February 10, 2020 Banking and Finance M&A Energy

Vinge has adviced a fund administrated by Marguerite with the acquisition and project financing of the Brännliden wind farm. Developed by the Swedish wind power developer OX2 AB, the Brännliden wind farm will have a total effect of approximately 42 MW. NORD/LB acted as lender.

The Vinge M&A team was led by Christoffer Thalin (Energy, M&A) who was supported by Mathias Lindquist (Environmental), Philip Åberg (Land, Grid) and Niklas Törnell (M&A).

The Vinge Banking & Finance team was led by Henrik Ossborn (Banking & Finance) who was supported by Fredrik Christiansson (Banking & Finance) and Jack Bengtsson (Banking & Finance).

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024